In this study, we analyzed the genetic characteristics of sorafenib-resistant AML cell subclusters using single-cell and bulk transcription data and found that sorafenib-resistant AML cells can promote BCL2 transcription by activating STAT3. The gene discussed is STAT3; the disease is acute myeloid leukemia.